Bio Medica Laboratories IPO Allotment Chances

Category-wise allotment probability for Bio Medica Laboratories SME IPO, estimated from live subscription data. Use the dropdown to check another IPO.

Select IPO

Bio Medica Laboratories IPO

Listed SME

Price Band

Rs 132 - 139

Lot Size

2000 shares

Total Subscription

2.19x

Allotment Chances — Bio Medica Laboratories IPO

Retail 39.0% (2.92x subscribed)

Moderate chance

S-HNI (2-10L) 45.7% (2.19x subscribed)

Moderate chance

B-HNI (>10L) 100.0% (1.02x subscribed)

High chance

If 100 retail investors apply, approximately 39 will get allotment.

Estimated from current subscription data, calibrated against published basis-of-allotment results. Actual allotment depends on the number of applications received and SEBI's allotment rules — draw of lots for Retail, Employee and NII; proportionate for QIB.

Applications Received — Bio Medica Laboratories IPO

Category	Applications	Subscription	Est. chance	Est. allottees
Retail	2,613	2.92x	39.0%	1,020
S-HNI (₹2–10L)	422	2.19x	45.7%	193
B-HNI (>₹10L)	35	1.02x	100.0%	35
QIB	6	15.94x	Proportionate	—
Total	3,076	2.19x	—	—

B-HNI odds for Bio Medica Laboratories use a correction of 4.00×, derived from this IPO's own lot value (₹2,78,000) rather than a fixed constant. Figures as reported at 4:58 pm, 25 May 2026 IST. QIB is allotted proportionately, so a draw-of-lots chance does not apply to it.

View Full Bio Medica Laboratories IPO Details

Explore More

Quick links to all IPO sections

▶️ Open IPO Live now ⭐ Best IPO Today Top picks 📅 Upcoming IPO Coming soon 📆 IPO Calendar Dates & schedule ✔️ Closed IPO Allotment pending 📈 Listed IPO Listing gains 🔥 IPO GMP Grey market premium 📊 Subscription Live bidding data 🏆 Allotment Check status 🏢 SME IPO Small & medium 🏦 Mainboard IPO Large cap 💰 Performance Listing returns 📚 Learn IPO guides

How these Bio Medica Laboratories figures are worked out

Chances start from 1 ÷ subscription times, corrected per category — B-HNI bid above ₹10 lakh but are allotted the same minimum NII lot as an S-HNI, so their real odds run several times better than the raw figure implies. The corrections are measured against published basis-of-allotment documents, not assumed. Read the full method and the measured figures, or see allotment chances for every open IPO.